WGS
GeneDx Holdings Corp.
NASDAQ: WGS · HEALTHCARE · DIAGNOSTICS & RESEARCH
$34.71
+0.58% today
Updated 2026-05-06
Market cap
$1.91B
P/E ratio
—
P/S ratio
4.48x
EPS (TTM)
$-0.73
Dividend yield
—
52W range
$55 – $171
Volume
1.0M
GeneDx Holdings Corp. (WGS) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$34.71
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$58.25
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.2B | $0.2B | $0.2B | $0.3B | $0.4B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -4.92%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.